11/15
09:21 am
bvs
Pressure Ulcers Treatment Markets, 2024-2028 & 2033 [Yahoo! Finance]
Low
Report
Pressure Ulcers Treatment Markets, 2024-2028 & 2033 [Yahoo! Finance]
11/6
01:10 pm
bvs
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $12.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Canaccord Genuity Group Inc. from $12.00 to $15.00. They now have a "buy" rating on the stock.
11/6
02:22 am
bvs
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]
Medium
Report
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... [Yahoo! Finance]
11/5
10:05 am
bvs
Bioventus (BVS) Matches Q3 Earnings Estimates [Yahoo! Finance]
Medium
Report
Bioventus (BVS) Matches Q3 Earnings Estimates [Yahoo! Finance]
11/5
07:56 am
bvs
Bioventus: Q3 Earnings Snapshot [Yahoo! Finance]
High
Report
Bioventus: Q3 Earnings Snapshot [Yahoo! Finance]
11/5
07:30 am
bvs
Bioventus Reports Third Quarter Financial Results
High
Report
Bioventus Reports Third Quarter Financial Results
11/4
11:43 am
bvs
Are Medical Stocks Lagging Bioventus (BVS) This Year? [Yahoo! Finance]
Medium
Report
Are Medical Stocks Lagging Bioventus (BVS) This Year? [Yahoo! Finance]
11/4
07:20 am
bvs
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
Low
Report
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For [Yahoo! Finance]
10/29
07:30 am
bvs
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
Low
Report
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
10/25
04:46 pm
bvs
Bioventus files for $200M mixed securities shelf [Seeking Alpha]
Low
Report
Bioventus files for $200M mixed securities shelf [Seeking Alpha]
10/1
11:07 am
bvs
Bioventus announces divestiture of its Advanced Rehabilitation business to Accelmed Partners [Seeking Alpha]
Low
Report
Bioventus announces divestiture of its Advanced Rehabilitation business to Accelmed Partners [Seeking Alpha]
10/1
09:00 am
bvs
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
Low
Report
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
9/27
09:16 am
bvs
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Craig Hallum from $12.00 to $17.00. They now have a "buy" rating on the stock.
Medium
Report
Bioventus Inc. (NYSE: BVS) had its price target raised by analysts at Craig Hallum from $12.00 to $17.00. They now have a "buy" rating on the stock.
9/23
05:15 pm
bvs
First September Gains in 5 Years? Buy 3 Breakout Stocks Now [Yahoo! Finance]
Low
Report
First September Gains in 5 Years? Buy 3 Breakout Stocks Now [Yahoo! Finance]
9/19
02:02 pm
bvs
Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy? [Yahoo! Finance]
Low
Report
Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy? [Yahoo! Finance]
8/29
08:41 am
bvs
Bull Of The Day: Bioventus (BVS) [Yahoo! Finance]
Neutral
Report
Bull Of The Day: Bioventus (BVS) [Yahoo! Finance]